Literature DB >> 7426442

Coagulation factors in the human fetus of about 20 weeks of gestational age.

J Terwiel, J J Veltkamp, R M Bertina, H P Muller.   

Abstract

In plasma samples of 11 fetuses of about 20 weeks of gestational age the following coagulation factors have been determined (mean values found are given in parentheses): fibrinogen (0.30 U/ml), prothrombin (+/-0.17 U/ml), factor V (0.28 U/ml), factor VII (0.21 U/ml), factor VIII coagulant activity (factor VIII:C) (0.12 U/ml), factor VIII-related antigen (factor VIIIR:Ag) (1.04 U/ml), coagulant factor VIII-related antigen (factor VII:CAg) (0.19 U/ml), factor IX coagulant activity (0.05 U/ml), factor IX antigen (less than or equal to 0.03 U/ml), factor X (0,19 U/ml) and antithrombin III (AT-III) (0.23 U/ml). Our data support the evidence that prenatal diagnosis of haemophilia A is at present possible; less optimism is warranted where haemophilia B is concerned. the number of samples is sufficient to establish normal values for the age group. Means of quality control of the sample-which is often difficult to obtain-are disscussed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7426442     DOI: 10.1111/j.1365-2141.1980.tb07187.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  3 in total

1.  Disparate temporal expression of the prothrombin and thrombin receptor genes during mouse development.

Authors:  S J Soifer; K G Peters; J O'Keefe; S R Coughlin
Journal:  Am J Pathol       Date:  1994-01       Impact factor: 4.307

2.  Incomplete embryonic lethality and fatal neonatal hemorrhage caused by prothrombin deficiency in mice.

Authors:  J Xue; Q Wu; L A Westfield; E A Tuley; D Lu; Q Zhang; K Shim; X Zheng; J E Sadler
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

Review 3.  The Vascular Endothelium and Coagulation: Homeostasis, Disease, and Treatment, with a Focus on the Von Willebrand Factor and Factors VIII and V.

Authors:  Juan A De Pablo-Moreno; Luis Javier Serrano; Luis Revuelta; María José Sánchez; Antonio Liras
Journal:  Int J Mol Sci       Date:  2022-07-27       Impact factor: 6.208

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.